Application 050316
- Type
- NDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LINCOCIN | LINCOMYCIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 250MG BASE | No | No |
| 002 | LINCOCIN | LINCOMYCIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 500MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050316-001 | LINCOCIN | LINCOMYCIN HYDROCHLORIDE | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | ||
| N050316-002 | LINCOCIN | LINCOMYCIN HYDROCHLORIDE | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N050316-001 | LINCOCIN | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N050316-002 | LINCOCIN | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N050316-001 | LINCOCIN | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N050316-002 | LINCOCIN | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N050316-001 | LINCOCIN | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N050316-002 | LINCOCIN | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N050316-001 | LINCOCIN | EQ 250MG BASE | CAPSULE / ORAL | Approved before 1982 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N050316-002 | LINCOCIN | EQ 500MG BASE | CAPSULE / ORAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LINCOMYCIN | LINCOMYCIN HYDROCHLORIDE | Henry Schein, Inc. | a7692968-7ac8-48ab-89a4-27c7803e31f4 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincocin | LINCOMYCIN HYDROCHLORIDE | Pharmacia & Upjohn Company LLC | c01906fa-2c73-4c13-9765-2fd06628d263 | 2025-03-10 | Boxed warning, Warnings, Adverse reactions | Lincocin LINCOMYCIN HYDROCHLORIDE |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 23f9608c-3126-35db-e063-6294a90af054 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | Sagent Pharmaceuticals | 75e149cc-b668-427e-bae7-a0d215e4fb7a | 2023-03-20 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | XGen Pharmaceuticals DJB, Inc. | 61f4851d-d919-400d-912a-05eb9dca11d4 | 2022-10-14 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| lincomycin hydrochloride | LINCOMYCIN HYDROCHLORIDE | Gland Pharma Limited | c2b5be20-cc6f-4221-9d3e-3f8b5886cd05 | 2022-09-28 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 7726 | SUPPL | 2004-06-07 |